Skip to content
Menu

Evotec Lands $2.9M Gates Foundation Grant Giving Global Health Researchers Continued Access To Stem Cell Platform For Early Drug Safety Assessment

Benzinga Newsdesk 4 days ago

News

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

New three-year grant from the Gates Foundation extends a 2023 project to help global health researchers predict potential fetal development risks posed by novel drug candidatesEvotec's human stem cell-based platform

  • New three-year grant from the Gates Foundation extends a 2023 project to help global health researchers predict potential fetal development risks posed by novel drug candidates
  • Evotec's human stem cell-based platform enables better-informed decisions regarding which drug candidates to advance into clinical testing
  • Continued collaboration underscores Evotec's capabilities in advanced human cell-based drug discovery technologies

Read at benzinga.com

← All stock news